Hemodialysis Market Share, Growth, and Demand Forecast 2024-2032

Global Hemodialysis Market Statistics: USD 126.7 Billion Value by 2032

Hemodialysis Industry

Summary:

  • The global hemodialysis market size reached USD 90.7 Billion in 2023.
  • The market is expected to reach USD 126.7 Billion by 2032, exhibiting a growth rate (CAGR) of 3.7% during 2024-2032.
  • North America leads the market, accounting for the largest hemodialysis market share.
  • Hemodialysis service accounts for the majority of the market share in the segment due to their simplicity, functionality, and aesthetic appeal. 
  • Conventional hemodialysis holds the largest share in the hemodialysis industry.
  • Based on the end-user, the market has been divided into hospitals, independent dialysis centers, and others.
  • The increasing incidence of chronic kidney disease (CKD) is is a primary driver of the hemodialysis market.
  • Technological innovations in dialysis equipment and techniques are reshaping the hemodialysis market.

Industry Trends and Drivers:

  • Rising Prevalence of Chronic Kidney Disease (CKD):

The increasing incidence of CKD is impelling the growth of the market. CKD affects millions of individuals globally, often due to underlying conditions like diabetes and hypertension. As the global rates of these chronic conditions continue to rise, so does the number of patients requiring dialysis to manage kidney failure. Hemodialysis serves as a life-sustaining treatment for individuals with end-stage renal disease (ESRD) or severe CKD, leading to consistent market growth. Additionally, delayed diagnosis and poor management of kidney-related diseases in low- and middle-income countries further escalate the demand for hemodialysis services. This growing patient population is increasing the need for advanced dialysis solutions, driving investments in the sector.

  • Advancements in Dialysis Technology:

Technological innovations in dialysis equipment and techniques are propelling the market growth. Continuous improvements in dialysis machines, such as enhanced blood flow monitoring, improved biocompatibility of membranes, and portable dialysis machines, are making treatment more efficient and less invasive. Additionally, innovations like wearable dialysis devices and home hemodialysis systems allow patients to undergo treatment in more comfortable, personalized settings, reducing the dependency on hospital visits. These advancements not only improve patient outcomes but also address the demand for better patient quality of life and convenience. As a result, companies in the market are heavily investing in research and development (R&D), accelerating the adoption of cutting-edge dialysis technologies, which is further supporting the market growth.

  • Increasing Geriatric Population:

The aging global population is another significant factor bolstering the hemodialysis market. Elderly individuals are more susceptible to CKD and other chronic conditions, such as diabetes and hypertension, which are leading causes of kidney failure. As life expectancy continues to rise, the elderly population's need for long-term care solutions, including dialysis, increases substantially. Hemodialysis provides a critical treatment option for managing kidney function in older patients who may not be suitable candidates for kidney transplantation due to age-related health complications. This growing geriatric demographic drives the demand for dialysis services. Additionally, the focus of the healthcare industry on improving care for the elderly ensures ongoing innovation and investment in hemodialysis solutions, further contributing to the market growth.

Request for a sample copy of this report: https://www.imarcgroup.com/hemodialysis-market/requestsample

Hemodialysis Market Report Segmentation:

Breakup By Segment:

  • Hemodialysis Product
    • Machines
    • Dialyzers
    • Others
  • Hemodialysis Service
    • In-center Services
    • Home Services

Hemodialysis service (in-center services and home services) represent the largest segment due to the increasing number of patients requiring routine dialysis treatments in specialized centers, ensuring consistent demand.

Breakup By Modality:

  • Conventional Hemodialysis
  • Short Daily Hemodialysis
  • Nocturnal Hemodialysis

Conventional hemodialysis holds the biggest market share because it is the most widely used treatment method, offering standardized care and frequent monitoring.

Breakup By End-User:

  • Hospitals
  • Independent Dialysis Centres
  • Others

Based on the end-user, the market has been divided into hospitals, independent dialysis centers, and others.

Breakup By Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

North America enjoys the leading position owing to its advanced healthcare infrastructure, high prevalence of kidney diseases, and favorable reimbursement policies.

Top Hemodialysis Market Leaders:

The hemodialysis market research report outlines a detailed analysis of the competitive landscape, offering in-depth profiles of major companies. Some of the key players in the market are:

  • Baxter International
  • Asahi Kasei Corporation
  • B. Barun Melsungen
  • DaVita
  • Cantel Medical Corporation
  • Fresenius Medical Care
  • Nipro Corporation
  • Rockwell Medical
  • Medivators
  • Toray Medical Company Ltd.
  • Nikkiso Co. Ltd.
  • Surni Group
  • Gambro
  • Satellite Healthcare Inc.
  • Renacon Pharma Ltd.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: [email protected]

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163